Search research articles
Contact Us
Filters
Showing results (1-10 of 83) with videos related to
Page
of 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 28, 2014
Optimizing research methods used for the evaluation of antimicrobial stewardship programs
Jessina C McGregor, Jon P Furuno
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 9, 2006
What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?
Anthony D Harris, Jessina C McGregor, Jon P Furuno
Therapeutics and Clinical Risk Management
|
February 12, 2009
Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis
Jessina C McGregor, George P Allen, David T Bearden
BMC Pharmacology & Toxicology
|
April 17, 2021
Opportunities for successful de-escalation of proton pump inhibitors at a federally qualified health center
Joelle Ayoub, Jessina C McGregor, Rebecca M Castner, et al.
CNS Drugs
|
June 27, 2012
Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study
Daniel M Hartung, Luke Middleton, Leanne Svoboda, et al.
American Journal of Infection Control
|
April 25, 2008
Economics of infection control surveillance technology: cost-effective or just cost?
Jon P Furuno, Marin L Schweizer, Jessina C McGregor, et al.
Neurology. Clinical Practice
|
September 26, 2022
Association Between Pharmacy Benefit Restrictions and Disease-Modifying Therapy Use in the Medicare Part D Program
Daniel M Hartung, Kirbee A Johnston, Jessina C McGregor, et al.
International Journal of MS Care
|
April 25, 2022
Characteristics of Prescription Drug Use Among Individuals With Multiple Sclerosis in the US Medicare Population
Daniel M Hartung, Kirbee A Johnston, Jessina C McGregor, et al.
Infection Control and Hospital Epidemiology
|
October 20, 2020
Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature
Lauren M Fontana, Angela Holly Villamagna, Monica K Sikka, et al.
Multiple Sclerosis and Related Disorders
|
October 8, 2020
The effect of out-of-pocket costs on initiation of disease-modifying therapies among medicare beneficiaries with multiple sclerosis
Daniel M Hartung, Kirbee A Johnston, Jessina C McGregor, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 83) with videos related to
Sort By:
Page
of 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 28, 2014
Optimizing research methods used for the evaluation of antimicrobial stewardship programs
Jessina C McGregor, Jon P Furuno
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 9, 2006
What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?
Anthony D Harris, Jessina C McGregor, Jon P Furuno
Therapeutics and Clinical Risk Management
|
February 12, 2009
Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis
Jessina C McGregor, George P Allen, David T Bearden
BMC Pharmacology & Toxicology
|
April 17, 2021
Opportunities for successful de-escalation of proton pump inhibitors at a federally qualified health center
Joelle Ayoub, Jessina C McGregor, Rebecca M Castner, et al.
CNS Drugs
|
June 27, 2012
Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study
Daniel M Hartung, Luke Middleton, Leanne Svoboda, et al.
American Journal of Infection Control
|
April 25, 2008
Economics of infection control surveillance technology: cost-effective or just cost?
Jon P Furuno, Marin L Schweizer, Jessina C McGregor, et al.
Neurology. Clinical Practice
|
September 26, 2022
Association Between Pharmacy Benefit Restrictions and Disease-Modifying Therapy Use in the Medicare Part D Program
Daniel M Hartung, Kirbee A Johnston, Jessina C McGregor, et al.
International Journal of MS Care
|
April 25, 2022
Characteristics of Prescription Drug Use Among Individuals With Multiple Sclerosis in the US Medicare Population
Daniel M Hartung, Kirbee A Johnston, Jessina C McGregor, et al.
Infection Control and Hospital Epidemiology
|
October 20, 2020
Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature
Lauren M Fontana, Angela Holly Villamagna, Monica K Sikka, et al.
Multiple Sclerosis and Related Disorders
|
October 8, 2020
The effect of out-of-pocket costs on initiation of disease-modifying therapies among medicare beneficiaries with multiple sclerosis
Daniel M Hartung, Kirbee A Johnston, Jessina C McGregor, et al.
Page
of 9